Structure |
Chemical Name |
CAS |
MF |
|
Mono-POC Tenofovir 6-Isopropyl CarbaMate |
1244022-56-7 |
C18H28N5O9P |
|
N-Methyl Iso Desloratadine |
183198-48-3 |
C20H21ClN2 |
|
酒石酸イソプロピルエステル |
116601-09-3 |
C7H12O6 |
|
Rivaroxaban Impurity 11 |
1411775-06-8 |
C14H17N3O4 |
|
(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl propionate |
|
C25H35NO3 |
|
Flomoxef Impurity 4 |
|
|
|
Nicardipine Impurity 5 |
|
|
|
11,11'-(PIPERAZINE-1,4-DIYL)-BIS-8-CHLORO-5H-DIBENZE[B,E][1,4]-DIAZEPINE |
263366-81-0 |
C30H24Cl2N6 |
|
Sacubitril Impurity 7 |
149709-44-4 |
C22H25NO5 |
|
Valsartan Impurity 5 |
1266616-11-8 |
C18H21N5 |
|
Milnacipran Impurity 4 |
1353644-49-1 |
C15H21NO2 |
|
2-アミノ-2-(4-ヘプチルフェネチル)-1,3-プロパンジオール |
745767-97-9 |
C18H31NO2 |
|
Tenofovir Fumarate |
1246812-23-6 |
C21H34N5O9P |
|
Prucalopride Impurity C |
1599434-55-5 |
C17H24ClN3O3 |
|
1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
2205053-60-5 |
C21H24FN3O4 |
|
Brexpiprazole N-Oxide |
1191900-58-9 |
C25H27N3O3S |
|
2,6-Dibenzyloxyacetophenone |
3886-19-9 |
C22H20O3 |
|
6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル |
1059630-08-8 |
C14H17BrN2O2 |
|
diphenhydramine impurity |
|
C17H21NO |
|
1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide |
|
C18H23IN4S |
|
2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid |
1657014-33-9 |
C16H16N2O3S |
|
vildagliptin Impurity O |
2253194-12-4 |
C12H18N4O2 |
|
methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
38990-17-9 |
C21H26N2O3 |
|
Canagliflozin Impurity 17 |
1951467-28-9 |
C24H23FO6S |
|
Canagliflozin Impurity 22 |
|
|
|
Carfilzomib Impurity 3 |
|
|
|
Dolutegravir Impurity 4 |
|
|
|
Febuxostat Impurity 20 |
|
|
|
Lenvatinib Impurity 1 |
|
|
|
methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
83508-82-1 |
C21H26N2O3 |
|
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester |
1941177-45-2 |
C29H37N7O3 |
|
Cabozantinib impurity 1 |
748707-58-6 |
C17H16N2O3 |
|
Amlodipine Impurity 19 |
|
C26H31ClN2O8S |
|
Amlodipine Impurity 9 |
90445-05-9 |
C26H31ClN2O8S |
|
Clopidogrel Impurity 7 |
444728-13-6 |
C15H15ClN2OS |
|
Rivaroxaban Impurity 36 |
1770812-39-9 |
C19H17Cl2N3O5S |
|
(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate |
1111177-24-2 |
C20H23N5O2 |
|
Clopidogrel Impurity C |
1346605-15-9 |
C16H18ClNO2S |
|
Nilotinib genotoxic impurity 2 |
1157857-29-8 |
C19H15F3N4O3 |
|
N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン |
1453221-45-8 |
C35H41F6N3O6 |
|
Gliclazide Impurity E |
|
|
|
Ethyl 1-butanesulfonate |
2374-68-7 |
C6H14O3S |
|
OLANEXIDINE intermediate |
60852-95-1 |
C10H20N4 |
|
1H-Isoindole, octahydro-, trans- |
10479-63-7 |
C8H15N |
|
1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |
155272-03-0 |
C18H20N4O4 |
|
Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)- |
181289-34-9 |
C9H17NO3 |
|
4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate |
65141-48-2 |
C8H10N4O7 |
|
2-(ACETOXYMETHYL)-4-METHOXY-3,5-DIMETHYLPYRIDINE |
91219-90-8 |
C11H15NO3 |
|
4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE |
112809-52-6 |
C17H11N5 |
|
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- |
93239-37-3 |
C24H30O5 |
|
Tadalafil EP impurity E |
|
|
|
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine |
134965-85-8 |
C12H7ClN6 |
|
(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile |
914070-99-8 |
C7H11N3O |
|
1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea |
1388858-78-3 |
C19H23FN2O2 |
|
Isavuconazole Impurity 48 |
|
|
|
5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-hydroxyquinolin-2(1H)-one) |
|
|
|
2-(4-(2-(4-(1-(2-methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid |
|
C27H35N3O3 |
|
Tafluprost Impurity 19 |
|
|
|
Rosuvastatin Impurity 162 |
|
|
|
Rosuvastatin Impurity 151 |
|
|
|
Rosuvastatin Impurity 148 |
|
|
|
フロセミドアシルグルクロニド |
72967-59-0 |
C18H19ClN2O11S |
|
Digoxin Impurity 1 |
|
|
|
(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
769908-13-6 |
C25H24FNO4 |
|
(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
261506-24-5 |
C34H49F5O4S |
|
1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid |
1163685-30-0 |
C14H11N3O3 |
|
O-Desethyl Candesartan Cilexetil |
869631-11-8 |
C31H30N6O6 |
|
Epi Lovastatin |
79952-44-6 |
C24H36O5 |
|
Hydroxy Brimonidine |
1216379-05-3 |
C11H12BrN5O |
|
7-メトキシ-3,4-ジヒドロキノリン-2(1H)-オン |
22246-17-9 |
C10H11NO2 |
|
N-ベンジル-1-(4-メトキシフェニル)プロパン-2-アミン塩酸塩 |
1049695-95-5 |
C17H21NO.HCl |
|
モンテルカストメチルケトン |
937275-23-5 |
C34H32ClNO3S |
|
Propyl Itraconazole |
74855-91-7 |
C34H36Cl2N8O4 |
|
3-methyleneisobenzofuran-1(3H)-one |
3453-63-2 |
C9H6O2 |
|
Irbesartan impurity A |
|
C25H28N6O |
|
(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine |
223673-35-6 |
C21H26N2O5 |
|
Azelastine N-Oxide |
640279-88-5 |
C22H24ClN3O2 |
|
4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド |
1193725-75-5 |
C19H15ClN2O2 |
|
16α,17,21-Trihydroxy-pregna-1,4-diene-3,11,20-trione |
3754-05-0 |
C21H26O6 |
|
4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity |
116182-43-5 |
C26H43NaO9 |
|
N-(3-エチニル-4-メチルフェニル)-6,7-ビス(2-メトキシエトキシ)キナゾリン-4-アミン |
1346601-52-2 |
C23H25N3O4 |
|
5-[[(4-フルオロフェニル)メチル]アミノ]-1,3-ジヒドロ-2H-イミダゾ[4,5-B]ピリジン-2-オン |
951624-49-0 |
C13H11FN4O |
|
ペリンドプリラットラクタムB |
130061-28-8 |
C17H26N2O4 |
|
シュードモン酸Dナトリウム |
85178-60-5 |
C26H41NaO9 |
|
N-DesMethyl SuMatriptan |
88919-51-1 |
C13H19N3O2S |
|
1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one |
220182-11-6 |
C10H20N4O |
|
Ropivacaine EP Impurity D |
98626-59-6 |
C16H24N2O |
|
Bendamustine Impurity 16 |
914626-65-6 |
C19H18N6O4 |
|
(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride |
959392-22-4 |
C18H19NOS |
|
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
|
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
|
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
|
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
|
3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン |
54528-00-6 |
C7H14N2 |
|
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
|
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
|
(3R)-3α,4α-(1,3-ジベンジルウレイレン)テトラヒドロチオフェン-5-オン |
28092-52-6 |
C19H18N2O2S |
|
(2S)-2-ピロリジンカルボン酸メチル |
2577-48-2 |
C6H11NO2 |
|
sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |
|
|
|
2,4,6-トリプロピル-1,3,5-トリオキサン |
2396-43-2 |
C12H24O3 |